Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02559362 · ClinicalTrials.gov registry record

Study on Breast Cancer Patient Perspectives of Exercise

A clinical trial, sponsored by Abramson Cancer Center at Penn Medicine.

Completed
Registry status
26
Enrollment target

NCT02559362 is a clinical trial that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 26 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02559362 has completed, sponsored by Abramson Cancer Center at Penn Medicine.

COMPLETED
Registry status
26 participants
Enrollment target

Study Summary

The goal of the study is to establish the feasibility/willingness of breast cancer patients to delay surgery to do an exercise program, or be randomized to an exercise training program following treatment, and to see if that willingness correlates with prior physical activity history.

Interventions

  • BEHAVIORAL Survey

Trial Details

FieldValue
Enrollment Target 26 participants
Start Date 2015-04
Est. Completion 2016-06-03

What the Registry Record Tells You About NCT02559362

The ClinicalTrials.gov registry entry for NCT02559362 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Survey is the first listed.

NCT02559362 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02559362 about?

NCT02559362 is a clinical study titled "Study on Breast Cancer Patient Perspectives of Exercise". The goal of the study is to establish the feasibility/willingness of breast cancer patients to delay surgery to do an exercise program, or be randomized to an exercise training program following treatment, and to see if that willingness correlates with prior physical activity history.

What is the current status of trial NCT02559362?

This trial is currently completed. The enrollment target is 26 participants. The study started on 2015-04. Estimated completion is 2016-06-03.

What interventions are being tested in trial NCT02559362?

The interventions under investigation include: Survey (BEHAVIORAL).

Who is sponsoring clinical trial NCT02559362?

This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.